HEP-G2/2.2.15 HUMAN CELL LINE

General description

Hepatocellular carcinoma is the primary malignancy of the liver and a leading cause of cancer-related death in the world. The etiology of hepatocellular carcinoma is closely linked to infection with hepatitis B virus (1). Because of the causative role of HBV in liver cancers, cellular models of HBV-infected hepatocellular carcinomas have been developed for understanding the progression and fundamental biology of liver cancers.

The Hep-G2/2.2.15 human hepatoblastoma cell line, a subclone of HepG2 human hepatoblastoma that stably expresses the hepatitis B virus, is one of the most widely used models for HBV-associated liver disease. Hep-G2/2.2.15 cells possess lower proliferation and invasion activity than parental HepG2 cells and have low tumorigenicity in nude mice (2). Like parental HepG2 cells, Hep-G2/2.2.15 cells express the microtubule-associated marker doublecortin (DCX).

<bold>Source:</bold>
Hep-G2/2.2.15 was produced from Hep-G2 cells stably transformed with the hepatitis-B virus (HBV) genome. Hep-G2/2.2.15 cells are resistant to G418 and contain two head-to-tail dimers of the HBV type D genome (3). The parental HepG2 cell line was isolated from hepatoblastoma tissue of a 15-year-old male patient (4).

Research Category:

• Cancer
• Infectious Diseases

Cell Line Origin

Human, Hepatocyte Cells;Cancer Cells

Packaging

&ge;1X10⁶ cells/vial

Storage and Stability

Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

Other Notes

This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.

Disclaimer

This product contains genetically modified organisms (GMO).
Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.